Boston Scientific Corp One Scimed Placemaple Grove Mn 55311 1566 Pma Numberp130013 Supplement Numbers054 Date Received09 29 2022 Decision Date10 28 2022 Product Code Ngv Advisory Committee Cardiovascular Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Boston Scientific Corp One Scimed Placemaple Grove Mn 55311 1566 Pma Numberp130013 Supplement Numbers054 Date Received09 29 2022 Decision Date10 28 2022 Product Code Ngv Advisory Committee Cardiovascular Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P130013S054 Boston Scientific Corp.one Scimed Placemaple Grove, MN 55311-1566 PMA NumberP130013 Supplement NumberS054 Date Received09/29/2022 Decision Date10/28/2022 Product Code NGV  Advisory Committee Cardiovascular Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted? No	WATCHMAN FLX™ Left Atrial Appendage Closure with Delivery System	2022-10-28